Skip to main content

Main menu

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Open access
    • COVID-19 submission information
    • Peer reviewer login
  • Alerts
  • Podcasts
  • Subscriptions
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

User menu

  • Log in
  • Subscribe
  • Contact Us
  • My Cart

Search

  • Advanced search
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

Login

European Respiratory Society

Advanced Search

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Open access
    • COVID-19 submission information
    • Peer reviewer login
  • Alerts
  • Podcasts
  • Subscriptions

Bacterial resistance induction with prophylactic antibiotics in COPD

Simon Brill, Martin Law, James Allinson, Ethaar El-Emir, Timothy McHugh, Gavin Donaldson, Dan Jackson, Michael Sweeting, Wisia Wedzicha
European Respiratory Journal 2014 44: P4731; DOI:
Simon Brill
1Centre for Respiratory Medicine, Royal Free Campus, University College London, London, United Kingdom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Martin Law
2MRC Biostatistics Unit, Institute of Public Health, University of Cambridge, Cambridge, United Kingdom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
James Allinson
1Centre for Respiratory Medicine, Royal Free Campus, University College London, London, United Kingdom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ethaar El-Emir
1Centre for Respiratory Medicine, Royal Free Campus, University College London, London, United Kingdom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Timothy McHugh
3UCL Centre for Clinical Microbiology, Royal Free Campus, University College London, London, United Kingdom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Gavin Donaldson
1Centre for Respiratory Medicine, Royal Free Campus, University College London, London, United Kingdom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Dan Jackson
2MRC Biostatistics Unit, Institute of Public Health, University of Cambridge, Cambridge, United Kingdom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Michael Sweeting
4Department of Public Health and Primary Care, University of Cambridge, Cambridge, United Kingdom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Wisia Wedzicha
1Centre for Respiratory Medicine, Royal Free Campus, University College London, London, United Kingdom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
Loading

Abstract

RATIONALE

Prophylactic antibiotic therapy prevents COPD exacerbations but concerns remain about induction of bacterial resistance.

METHOD

During a 13-week single-blind randomised placebo-controlled trial, patients with COPD and FEV1<80% received moxifloxacin 400mg/day on 5 days every 4 weeks, doxycycline 100mg/day, azithromycin 250mg 3x/week or placebo daily. Mean inhibitory concentrations(MIC) were obtained for bacterial isolates cultured from sputum pre- and post-treatment. Analysis was with linear mixed effects models and logistic regression.

RESULTS

237 isolates were detected and tested in 69 patients and dichotomised (resistant/not) where possible. Compared to placebo, post-treatment MIC was 4.79 times higher in patients who received moxifloxacin (95%CI 1.43,16.03, p=0.01), 6.23 for azithromycin (1.66,23.35, p=0.01) and 3.74 for doxycycline (1.46,9.58, p=0.01). Isolates in the doxycycline group were more likely to be resistant post-treatment than placebo (odds ratio 5.77 [1.41,23.66], p=0.01); odds ratios for moxifloxacin and azithromycin were >2 but non-significant. There was no difference in number of isolates cultured between groups post-treatment. Figure 1 shows pre/post-treatment MICs.

CONCLUSION

Each antibiotic was associated with a significant increase in the MIC of cultured isolates; odds of an isolate being clinically resistant also increased with doxycycline. The potential consequences of this observation require further investigation.

Figure
  • Download figure
  • Open in new tab
  • Download powerpoint

  • COPD - management
  • Bacteria
  • COPD - exacerbations
  • © 2014 ERS
Previous
Back to top
Vol 44 Issue Suppl 58 Table of Contents
  • Table of Contents
  • Index by author
Email

Thank you for your interest in spreading the word on European Respiratory Society .

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Bacterial resistance induction with prophylactic antibiotics in COPD
(Your Name) has sent you a message from European Respiratory Society
(Your Name) thought you would like to see the European Respiratory Society web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Bacterial resistance induction with prophylactic antibiotics in COPD
Simon Brill, Martin Law, James Allinson, Ethaar El-Emir, Timothy McHugh, Gavin Donaldson, Dan Jackson, Michael Sweeting, Wisia Wedzicha
European Respiratory Journal Sep 2014, 44 (Suppl 58) P4731;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Bacterial resistance induction with prophylactic antibiotics in COPD
Simon Brill, Martin Law, James Allinson, Ethaar El-Emir, Timothy McHugh, Gavin Donaldson, Dan Jackson, Michael Sweeting, Wisia Wedzicha
European Respiratory Journal Sep 2014, 44 (Suppl 58) P4731;
del.icio.us logo Digg logo Reddit logo Technorati logo Twitter logo CiteULike logo Connotea logo Facebook logo Google logo Mendeley logo

Jump To

  • Article
  • Figures & Data
  • Info & Metrics
  • Tweet Widget
  • Facebook Like
  • Google Plus One

More in this TOC Section

  • Prevalence and clinical correlates of patient-reported autonomic symptoms among subjects with COPD
  • Role of serum and tissue vascular remodeling markers in bone loss related to end-stage COPD
  • Relationship between blood eosinophil count (Eos), clinical characteristics and mortality of patients with COPD
Show more 1.12 Clinical Problems - COPD

Related Articles

Navigate

  • Home
  • Current issue
  • Archive

About the ERJ

  • Journal information
  • Editorial board
  • Reviewers
  • Press
  • Permissions and reprints
  • Advertising

The European Respiratory Society

  • Society home
  • myERS
  • Privacy policy
  • Accessibility

ERS publications

  • European Respiratory Journal
  • ERJ Open Research
  • European Respiratory Review
  • Breathe
  • ERS books online
  • ERS Bookshop

Help

  • Feedback

For authors

  • Instructions for authors
  • Publication ethics and malpractice
  • Submit a manuscript

For readers

  • Alerts
  • Subjects
  • Podcasts
  • RSS

Subscriptions

  • Accessing the ERS publications

Contact us

European Respiratory Society
442 Glossop Road
Sheffield S10 2PX
United Kingdom
Tel: +44 114 2672860
Email: journals@ersnet.org

ISSN

Print ISSN:  0903-1936
Online ISSN: 1399-3003

Copyright © 2023 by the European Respiratory Society